Immunic, Inc. - Common Stock (IMUX)
0.9700
+0.0067 (0.70%)
NASDAQ · Last Trade: Oct 3rd, 3:37 PM EDT
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Via Benzinga · September 29, 2025
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Via Benzinga · September 29, 2025
Via Stocktwits · July 7, 2025
Via Stocktwits · July 7, 2025
Via Stocktwits · July 7, 2025
Via Stocktwits · July 2, 2025
Via Stocktwits · July 2, 2025
Via Stocktwits · July 2, 2025
Via Stocktwits · July 2, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · May 29, 2025

Via Benzinga · May 28, 2025
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · April 30, 2025
Via Benzinga · April 30, 2025
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · April 30, 2025
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · April 30, 2025
Via Benzinga · April 30, 2025
Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes.
Via Stocktwits · April 9, 2025

Via Benzinga · September 16, 2024

While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying.
Via InvestorPlace · May 23, 2024

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
Via News Direct · May 20, 2024

Immunic chief medical officer discusses promising treatments to mark World IBD Day
Via News Direct · May 17, 2024

Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
Via News Direct · May 16, 2024